Clinical trials
Community-acquired Pneumonia clinical trials
Below are recruiting community-acquired pneumonia clinical trials, each written for real people, not researchers. We’re tracking 35 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07099976Recruiting
Better pneumonia treatment for kids in the ER
This trial tests a treatment plan for children with pneumonia who can be treated at home. It aims to find the best way to help kids get better faster and avoid complications.
Calgary, AlbertaAges 6 months–18 years - NCT07164131RecruitingPhase 4
Comparing two antibiotics for pneumonia in hospital
This trial compares azithromycin and doxycycline for adults hospitalized with community-acquired pneumonia who are already getting a beta-lactam antibiotic. It aims to see which works better as an add-on treatment.
Scottsdale, ArizonaAges 18 years+ - NCT07278700Recruiting
Fever and respiratory infection study
This study looks at adults with a fever caused by a respiratory infection. If you qualify, you will have a blood draw as part of your regular care, and researchers will use it to learn more about your condition.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07359287Recruiting
Study on antibiotic use for respiratory infections
This study tests a program to help doctors prescribe antibiotics more carefully for common respiratory infections like colds, flu, bronchitis, and sinusitis. It may lead to better treatment for you.
CaenAges Any age - NCT02735707RecruitingPhase 3
Adaptive trial for severe pneumonia care in intensive care
This study tests ways to improve treatment for adults with severe pneumonia that lands them in the ICU, adjusting the plan as results come in. It may help your care team find better treatments for lung infection and breathing/heart support needs.
Jacksonville, FloridaAges 18 years+ - NCT07442656Recruiting
Frailty and outcomes in older adults with pneumonia
This study looks at how frailty (overall weakness and decline) affects recovery in older adults who come to the emergency room with pneumonia. The goal is to understand what outcomes patients can expect based on their frailty level.
Izmir, BornovaAges 65 years+ - NCT07070284Enrolling by invitation
Severe pneumonia in older adults: a study of risks and outcomes
This study looks at older adults with severe pneumonia to understand what causes it and how to improve outcomes. If you are 65 or older and have severe pneumonia, this trial may help doctors learn more about your condition.
Zagreb, City of ZagrebAges 65 years+ - NCT07011433Enrolling by invitation
Pneumonia germs, inflammation, and recovery
This study looks at how certain parts of the bacteria that cause pneumonia (called virulence factors) and your body's natural inflammation markers are related to how well you recover. The goal is to learn more about what affects pneumonia outcomes, which could help doctors personalize treatment.
KaunasAges 18 years+ - NCT07759934RecruitingPhase 2
Comparing ASK0912 to polymyxin B for hospital-acquired pneumonia
This study compares an experimental antibiotic called ASK0912 with an approved antibiotic (polymyxin B) in adults with hospital-acquired or ventilator-associated pneumonia. It aims to see if the new drug is as effective and safe as the standard treatment.
Nanjing, JiangsuAges 18 years+ - NCT06602934Recruiting
Pneumonia, heart health, and your body's germs
This study looks at how pneumonia affects the long-term health of your heart and lungs by studying the germs that live in your body. It may help doctors understand why some people get worse and how to better protect your heart after a serious infection.
AngersAges 18–80 - NCT06841731RecruitingPhase 2
Testing a new antibiotic for hospital-acquired pneumonia
This trial tests a new antibiotic called HRS-8427 for adults with bacterial pneumonia that started in the hospital or while on a ventilator. It may be an option if you need IV antibiotics and haven't already received long-term treatment for this infection.
Beijing, Beijing MunicipalityAges 18 years+
Hear when a new Community-acquired Pneumonia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for community-acquired pneumonia?
- Yes. Clin2 currently lists 35 recruiting community-acquired pneumonia studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a community-acquired pneumonia trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a community-acquired pneumonia trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.